Open AccessEffective treatment of advanced Hodgkin lymphoma with a modified BEACOPP regimen for a patient with demyelinating hereditary motor and sensory neuropathy type 1 (HMSN1)
Author(s) -
Hess Patrick P.,
Ventura Ferreira Monica S.,
Rolles Benjamin,
Kirschner Martin,
Holtbernd Florian,
Tometten Mareike,
Brümmendorf Tim H.,
Beier Fabian
Publication year - 2022
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5766
Subject(s) - medicine , lymphoma , chemotherapy , regimen , neurotoxicity , disease , sensory neuropathy , peripheral neuropathy , oncology , surgery , toxicity , endocrinology , diabetes mellitus
Treatment for Hodgkin lymphoma (HL) in adults comprises substantial risk of chemotherapy‐induced peripheral neurotoxicity. Here, we describe the case of patient with Charcot–Marie–Tooth disease or HSMN1 and advanced Hodgkin lymphoma undergoing treatment with modified BEACOPP achieving complete remission without major aggravation of neurological symptoms.